Association between TAAR6 polymorphisms and airway responsiveness to inhaled corticosteroids in asthmatic patients

Pharmacogenetics and Genomics

Volumn 25, Issue 7, 2015, Pages 334-342

  Chang, Hun Soo ^a   Heo, Jeong Seok ^a   Shin, Seung Woo ^b   Bae, Da Jeong ^a   Song, Hyun Ji ^a   Jun, Ji Ae ^a   Kim, Jeong Dong ^a   Park, Jong Sook ^a,b   Park, Byung Lae ^c   Shin, Hyung Doo ^c,d   Park, Choon Sik ^a,b  

^a Soonchunhyang University   (South Korea)

^b Division for Allergy and Respiratory Diseases   (South Korea)

^c SNP Genetics Inc   (South Korea)

^d Sogang University   (South Korea)

Author keywords

Asthma; corticosteroid; pharmacogenetics; single nucleotide polymorphism; TAAR6

Indexed keywords

FLUTICASONE PROPIONATE; PROTEIN; TRACE AMINE ASSOCIATED RECEPTOR 6; UNCLASSIFIED DRUG; ANTIINFLAMMATORY AGENT; CELL CYCLE PROTEIN; CORTICOSTEROID; FLUTICASONE; NUCLEAR PROTEIN; TRACE AMINE RECEPTOR 4, HUMAN;

ADOLESCENT; ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; CORTICOSTEROID THERAPY; DNA FLANKING REGION; DRY POWDER INHALER; FEMALE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HOMOZYGOTE; HUMAN; LUNG FUNCTION; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MILD PERSISTENT ASTHMA; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEVERE PERSISTENT ASTHMA; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TREATMENT DURATION; TREATMENT RESPONSE; 3' UNTRANSLATED REGION; ASTHMA; CONTROLLED CLINICAL TRIAL; DRUG EFFECTS; GENETIC ASSOCIATION STUDY; GENETICS; INHALATIONAL DRUG ADMINISTRATION; MIDDLE AGED; PATHOPHYSIOLOGY; YOUNG ADULT;

3' UNTRANSLATED REGIONS; ADMINISTRATION, INHALATION; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ASTHMA; CELL CYCLE PROTEINS; FEMALE; FLUTICASONE; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84931082356     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0000000000000141     Document Type: Article

References (44)

1. Green RH, Brightling CE, Bradding P. The reclassification of asthma based on subphenotypes. Curr Opin Allergy Clin Immunol 2007; 7:43-50.
2. Kamada AK, Szefler SJ, Martin RJ, Boushey HA, Chinchilli VM, Drazen JM, et al. Issues in the use of inhaled glucocorticoids. The Asthma Clinical Research Network. Am J Respir Crit Care Med 1996; 153 (6 Pt 1):1739-1748.
3. GINA, G.I.F.A. Global strategy for asthma management and prevention Nhlbi/Who Workshop Report. Bethesda, MD: National Institutes of Health National Heart, Lung, and Blood Institute; 2002.
4. Jang AS, Lee JH, Park SW, Lee YM, Uh ST, Kim YH, Park CS. Factors influencing the responsiveness to inhaled glucocorticoids of patients with moderate-to-severe asthma. Chest 2005; 128:1140-1145.
5. Malmstrom K, Rodriguez-Gomez G, Guerra J, Villaran C, Piñeiro A, Wei LX, et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med 1999; 130:487-495.
6. Szefler SJ, Martin RJ, King TS, Boushey HA, Cherniack RM, Chinchilli VM, et al. Significant variability in response to inhaled corticosteroids for persistent asthma. J Allergy Clin Immunol 2002; 109:410-418.
7. Bray PJ, Cotton RG. Variations of the human glucocorticoid receptor gene (NR3C1): pathological and in vitro mutations and polymorphisms. Hum Mutat 2003; 21:557-568.
8. Tantisira KG, Lake S, Silverman ES, Palmer LJ, Lazarus R, Silverman EK, et al. Corticosteroid pharmacogenetics: association of sequence variants in CRHR1 with improved lung function in asthmatics treated with inhaled corticosteroids. Hum Mol Genet 2004; 13:1353-1359.
9. Jin J, Arias EE, Chen J, Harper JW, Walter JC. A family of diverse Cul4-Ddb1-interacting proteins includes Cdt2, which is required for S phase destruction of the replication factor Cdt1. Mol Cell 2006; 23:709-721.
10. Tantisira KG, Hwang ES, Raby BA, Silverman ES, Lake SL, Richter BG, et al. TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids. Proc Natl Acad Sci USA 2004; 101:18099-18104.
11. Cho SH, Park BL, Shin SW, Heo JS, Park JS, Park SW, et al. Association between WDR21A polymorphisms and airway responsiveness to inhaled corticosteroids in asthmatic patients. Pharmacogenet Genomics 2012; 22:327-335.
12. Iordanidou M, Paraskakis E, Tavridou A, Paschou P, Chatzimichael A, Manolopoulos VG. G894t polymorphism of enos gene is a predictor of response to combination of inhaled corticosteroids with long-lasting beta2-agonists in asthmatic children. Pharmacogenomics 2012; 13:1363-1372.
13. Berce V, Kozmus CE, Potocnik U. Association among Ormdl3 gene expression, 17q21 polymorphism and response to treatment with inhaled corticosteroids in children with asthma. Pharmacogenomics J 2013; 13:523-529.
14. Kim MH, Kim SH, Kim YK, Hong SJ, Min KU, Cho SH, Park HW. A polymorphism in the histone deacetylase 1 gene is associated with the response to corticosteroids in asthmatics. Korean J Intern Med 2013; 28:708-714.
15. Zuurhout MJ, Vijverberg SJ, Raaijmakers JA, Koenderman L, Postma DS, Koppelman GH, et al. Arg16 Adrb2 genotype increases the risk of asthma exacerbation in children with a reported use of long-acting beta2-agonists: results of the pacman cohort. Pharmacogenomics 2013; 14:1965-1971.
16. Park HW, Dahlin A, Tse S, Duan QL, Schuemann B, Martinez FD, et al. Genetic predictors associated with improvement of asthma symptoms in response to inhaled corticosteroids. J Allergy Clin Immunol 2014; 133:664-669.e5.
17. Park TJ, Park JS, Cheong HS, Park BL, Kim LH, Heo JS, et al. Genome-wide association study identifies allc polymorphisms correlated with FEV change by corticosteroid. Clin Chim Acta 2014; 436c:20-26.
18. Burchett SA, Hicks TP. The mysterious trace amines: protean neuromodulators of synaptic transmission in mammalian brain. Prog Neurobiol 2006; 79:223-246.
19. Davis BA, Boulton AA. The trace amines and their acidic metabolites in depression-an overview. Prog Neuropsychopharmacol Biol Psychiatry 1994; 18:17-45.
20. Hawthorn MH, Broadley KJ, Gibbon CJ. Examination of the bronchoconstrictor response of guinea-pig isolated lung to betaphenylethylamine. Gen Pharmacol 1985; 16:371-378.
21. Cortijo J, Esplugues J, Morcillo EJ, Perpinã M. Pharmacological analysis of the responsiveness of guinea-pig lung parenchymal strip to dopamine. Br J Pharmacol 1984; 83:161-167.
22. Davis C, Kannan MS. Sympathetic innervation of human tracheal and bronchial smooth muscle. Respir Physiol 1987; 68:53-61.
23. Danielson TJ, Boulton AA, Robertson HA. m-Octopamine, p-octopamine and phenylethanolamine in rat brain: a sensitive, specific assay and the effects of some drugs. J Neurochem 1977; 29:1131-1135.
24. Jones RS. Tryptamine: a neuromodulator or neurotransmitter in mammalian brain? Prog Neurobiol 1982; 19:117-139.
25. Strassman RJ, Qualls CR. Dose-response study of N, N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects. Arch Gen Psychiatry 1994; 51:85-97.
26. Hedrick PW. Gametic disequilibrium measures: proceed with caution. Genetics 1987; 117:331-341.
27. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-989.
28. Nyholt DR. Genetic case-control association studies-correcting for multiple testing. Hum Genet 2001; 109:564-567.
29. Lange P, Parner J, Vestbo J, Schnohr P, Jensen G. A 15-year follow-up study of ventilatory function in adults with asthma. N Engl J Med 1998; 339:1194-1200.
30. Ward C, Pais M, Bish R, Reid D, Feltis B, Johns D, Walters EH. Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax 2002; 57:309-316.
31. Gagliardo R, Chanez P, Vignola AM, Bousquet J, Vachier I, Godard P, et al. Glucocorticoid receptor alpha and beta in glucocorticoid dependent asthma. Am J Respir Crit Care Med 2000; 162:7-13.
32. Kraft M, Vianna E, Martin RJ, Leung DY. Nocturnal asthma is associated with reduced glucocorticoid receptor binding affinity and decreased steroid responsiveness at night. J Allergy Clin Immunol 1999; 103 (Pt 1):66-71.
33. Sher ER, Leung DY, Surs W, Kam JC, Zieg G, Kamada AK, Szefler SJ. Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy. J Clin Invest 1994; 93:33-39.
34. Borowsky B, Adham N, Jones KA, Raddatz R, Artymyshyn R, Ogozalek KL, et al. Trace amines: identification of a family of mammalian G protein-coupled receptors. Proc Natl Acad Sci USA 2001; 98:8966-8971.
35. Vladimirov VI, Maher BS, Wormley B, O'neill FA, Walsh D, Kendler KS, et al. The trace amine associated receptor (Taar6) gene is not associated with schizophrenia in the Irish case-control study of schizophrenia (Iccss) sample. Schizophr Res 2009; 107:249-254.
36. Pae CU, Drago A, Kim JJ, Patkar AA, Jun TY, De Ronchi D, Serretti A. TAAR6 variations possibly associated with antidepressant response and suicidal behavior. Psychiatry Res 2010; 180:20-24.
37. Vladimirov V, Thiselton DL, Kuo PH, McClay J, Fanous A, Wormley B, et al. A region of 35 kb containing the trace amine associate receptor 6 (TAAR6) gene is associated with schizophrenia in the Irish study of high-density schizophrenia families. Mol Psychiatry 2007; 12:842-853.
38. Pedersen MS, Benros ME, Agerbo E, Børglum AD, Mortensen PB. Schizophrenia in patients with atopic disorders with particular emphasis on asthma: a Danish population-based study. Schizophr Res 2012; 138:58-62.
39. Chen YH, Lee HC, Lin HC. Prevalence and risk of atopic disorders among schizophrenia patients: a nationwide population based study. Schizophr Res 2009; 108:191-196.
40. Kino T, Tiulpakov A, Ichijo T, Chheng L, Kozasa T, Chrousos GP. G protein beta interacts with the glucocorticoid receptor and suppresses its transcriptional activity in the nucleus. J Cell Biol 2005; 169:885-896.
41. Chen Y, Stephan W. Compensatory evolution of a precursor messenger RNA secondary structure in the Drosophila melanogaster Adh gene. Proc Natl Acad Sci USA 2003; 100:11499-11504.
42. Yang TP, Beazley C, Montgomery SB, Dimas AS, Gutierrez-Arcelus M, Stranger BE, et al. Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies. Bioinformatics 2010; 26:2474-2476.
43. Cochrane MG, Bala MV, Downs KE, Mauskopf J, Ben-Joseph RH. Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique. Chest 2000; 117:542-550.
44. Van der Palen J, Klein JJ, Rovers MM. Compliance with inhaled medication and self-treatment guidelines following a self-management programme in adult asthmatics. Eur Respir J 1997; 10:652-657.